The activation of this pathway endows gastric cancer cells with stem cell characteristics and enhances their resistance to 5-fluorouracil (5-FU).544 METTL3, an m6A “writer,” affects chemotherapy resistance by regulating autophagic degradation. The gene discussed is METTL3; the disease is gastric cancer.